Hikal Limited — Important, 08-02-2025: Updates

The inspection of Hikal Ltd.'s Jigani unit by the US FDA has concluded, resulting in six observations. The company plans to address these observations and will submit a response within the required timeline. This development could impact Hikal's operations if not resolved promptly, so stakeholders should monitor the situation closely. Addressing these observations effectively is crucial, as it affects the unit's compliance and the company’s reputation in the market.